Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 11472710)

1.

Pleiotropic effects of statins and their clinical significance.

LaRosa JC.

Am J Cardiol. 2001 Aug 1;88(3):291-3. Review. No abstract available.

PMID:
11472710
2.

[What other effects do statins have except their effect on lipids?].

Tikkanen MJ.

Duodecim. 1998;114(13):1299-301. Finnish. No abstract available.

PMID:
11552256
3.

[Some aspects of pleiotropic effects of statins in internal medicine].

Switalski M.

Pol Arch Med Wewn. 2003 Oct;110(4):1173-9. Review. Polish. No abstract available.

PMID:
14699676
4.

Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?

Comparato C, Altana C, Bellosta S, Baetta R, Paoletti R, Corsini A.

Nutr Metab Cardiovasc Dis. 2001 Oct;11(5):328-43. Review.

PMID:
11887430
5.
6.

Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I.

Shah PK, Kaul S, Nilsson J, Cercek B.

Circulation. 2001 Nov 6;104(19):2376-83. Review. No abstract available.

7.

[Statins: therapeutic cascade of their effects].

Aronov DM.

Kardiologiia. 2004;44(10):85-94. Review. Russian.

PMID:
15477799
8.

[Do the pleiotropic effects of statins have a clinical significance?].

Vergès B.

Arch Mal Coeur Vaiss. 2004 Dec;97(12):1231-5. Review. French.

PMID:
15669365
9.

Antiphospholipid antibodies and the endothelium.

Hunt BJ, Khamashta MA.

Curr Rheumatol Rep. 2000 Jun;2(3):252-5. Review.

PMID:
11123067
10.

[Pleiotropic effects of statins].

Westerweel PE, Verhaar MC, Rabelink TJ.

Ned Tijdschr Geneeskd. 2004 Jul 17;148(29):1431-5. Review. Dutch.

PMID:
15326645
11.

[New insights in the pathogenesis of prothrombotic state associated with hypercholesterolemia].

Ferroni P, Basili S, Davì G.

Recenti Prog Med. 2004 Mar;95(3):169-78. Review. Italian.

PMID:
15143955
12.

Beyond lipid-lowering: effects of statins on endothelial nitric oxide.

Laufs U.

Eur J Clin Pharmacol. 2003 Mar;58(11):719-31. Epub 2003 Feb 18. Review.

PMID:
12634978
13.
14.

Endothelium-dependent effects of statins.

Wolfrum S, Jensen KS, Liao JK.

Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):729-36. Epub 2003 Feb 27. Review.

15.

Statins in ischemic stroke: just low-density lipoprotein lowering or more?

Stead LG, Vaidyanathan L, Kumar G, Bellolio MF, Brown RD Jr, Suravaram S, Enduri S, Gilmore RM, Decker WW.

J Stroke Cerebrovasc Dis. 2009 Mar-Apr;18(2):124-7. doi: 10.1016/j.jstrokecerebrovasdis.2008.09.016.

PMID:
19251188
16.

[Statins, inflammation and atherosclerotic damage].

Blanco-Colio LM, Martín-Ventura JL, Gómez-Hernández A, Egido J.

Nefrologia. 2004;24 Suppl 4:17-20. Spanish. No abstract available.

PMID:
15279380
17.

Statins and angiotensin II-induced vascular injury.

Dechend R, Müller D, Park JK, Fiebeler A, Haller H, Luft FC.

Nephrol Dial Transplant. 2002 Mar;17(3):349-53. No abstract available.

18.

Role of statin pleiotropism in acute coronary syndromes and stroke.

Liao JK.

Int J Clin Pract Suppl. 2003 Mar;(134):51-7. Review.

PMID:
12793598
19.

Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.

Palinski W, Tsimikas S.

J Am Soc Nephrol. 2002 Jun;13(6):1673-81. Review.

20.

LOX-1 and atherosclerosis: proof of concept in LOX-1-knockout mice.

Morawietz H.

Circ Res. 2007 Jun 8;100(11):1534-6. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk